MKI67 and neoplasm: Immunohistochemical analysis of tumor sections revealed enhanced expression of Ki67 in CM of Act RAW264.7 treated tumor which was inhibited after neutralization of IL-6 suggesting that TAM derived IL-6 induced cell proliferation in breast cancer (Fig. 6F).